©2025 Stanford Medicine
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Not Recruiting
Trial ID: NCT01144780
Purpose
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.
Official Title
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Stanford Investigator(s)
Jason Gotlib
Professor of Medicine (Hematology)
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Stephen Oh
650-723-7875